Baorui Liu

机构：Nanjing Drum Tower Hospital, Chinese Academy of Agricultural Sciences, Feed Research Institute · ORCID：0000-0002-2539-7732

发表论文 563 篇 · 总被引 12820 次 · h-index 55

代表论文

• Mesothelin-directed protein-drug conjugates for mesothelin-low solid tumor therapy (2025 · Nature Communications · 被引 11)
• Corrigendum: Efficacy and safety of PD-1/PD-L1 inhibitors as first-line treatment for esophageal squamous cell carcinoma: a systematic review and meta-analysis (2025 · Frontiers in Immunology · 被引 6)
• Engineered Mycobacterium smegmatis expressing anti-PD-L1/IL-15 immunocytokine induces and activates specific antitumor immunity (2025 · Journal for ImmunoTherapy of Cancer · 被引 4)
• Improved Hypoxic Microenvironment By Nanoformulation For Effective T Cell Therapy In Mice Model (2025 · International Journal of Nanomedicine · 被引 3)
• Tislelizumab and Hypofractionated Radiotherapy plus Nab-Paclitaxel/Gemcitabine as Conversion Therapy for BRPC/LAPC: A Phase II Trial with Dynamic Biomarker Monitoring (2025 · Clinical Cancer Research · 被引 1)
• De novo design of a two-step approach targeting Claudin-6 for enhanced drug delivery to solid tumors (2025 · Journal of Translational Medicine · 被引 1)